Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories tax Compliance & Advisory Fees ($M) ($M)
Form DEF 14A Proxy Statement (Audit Fees)
Latest, FY2025
5,767,000
Period ended Dec 31, 2025
Change on a year earlier
-7.6%
6,241,000 in FY2024
History
8 years
Since FY2018
Sources
7
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Tax Compliance & Advisory Fees ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5,767,000 | -7.6% | SEC Filing (0001308179-26-000064) ↗ |
| FY2024 | Dec 31, 2024 | 6,241,000 | -14.6% | SEC Filing (0001308179-26-000064) ↗ |
| FY2023 | Dec 31, 2023 | 7,304,000 | +5.6% | SEC Filing (0001308179-25-000134) ↗ |
| FY2022 | Dec 31, 2022 | 6,916,000 | +11.3% | SEC Filing (0001308179-24-000182) ↗ |
| FY2021 | Dec 31, 2021 | 6,216,000 | +4.6% | SEC Filing (0001308179-23-000247) ↗ |
| FY2020 | Dec 31, 2020 | 5,944,000 | -10.9% | SEC Filing (0001206774-22-000778) ↗ |
| FY2019 | Dec 31, 2019 | 6,668,000 | -25.1% | SEC Filing (0001047469-21-000592) ↗ |
| FY2018 | Dec 31, 2018 | 8,905,000 | – | SEC Filing (0001047469-20-001466) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Tax Compliance & Advisory Fees ($M) ($M), annual FY2018–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/audit-tax-fees
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.